MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2024 International Congress

    Plasma Biomarkers of Alzheimer’s Pathology Identify Prodromal Dementia with Lewy bodies

    A. Delva, A. Pelletier, E. Sommerville, J. Montplaisir, J. Gagnon, G. Kollmorgen, T. Kam-Thong, T. Kustermann, V. Machado, Z. Gan-Or, R. Postuma (Montreal, Canada)

    Objective: To determine whether plasma biomarkers of Alzheimer’s disease (AD) pathology can predict phenoconversion from idiopathic/isolated REM sleep behavior disorder (iRBD) to dementia with Lewy…
  • 2024 International Congress

    Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

    S. Hussain (New Delhi, India)

    Objective: To investigate the potential association between the use of DPP-4 inhibitors and the risk of dementia, utilizing real-world data from diverse sources. Background: Evidence…
  • 2024 International Congress

    Expanding Diversity of Parkinson’s Disease and Related Disorders Genetic Data: from the Global Parkinson’s Genetics Program

    G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)

    Objective: To expand the research dataset for Parkinson’s Disease (PD) and related disorders by including >50,000 participants globally who have been genotyped or whole genome…
  • 2024 International Congress

    Sex Differences for Regional Lewy Body Pathology in Pathologically-Defined Lewy Body Dementia

    E. Bayram, D. Coughlin, S. Koga, I. Litvan, D. Dickson (La Jolla, USA)

    Objective: To investigate sex differences for regional Lewy body (LB) pathology burden, and regional LB pathology association with clinical diagnosis across people with a high…
  • 2024 International Congress

    Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort

    M. Brumm, T. Simuni, C. Gochanour, L. Chahine, K. Poston, S. Chowdhury, C. Coffey, T. Dam, P. Dibiaso, T. Foroud, M. Fraiser, K. Kieburtz, C. Kopil, K. Merchant, B. Mollenhauer, G. Pagano, J. Seibyl, T. Sherer, D. Stephenson, C. Tanner, E. Tolosa, D. Weintraub, Y. Xiao, A. Siderowf, B. Dunn, K. Marek (Iowa City, USA)

    Objective: To apply biological definition and Neuronal α-Synuclein Disease Integrated Staging System (NSD-ISS) to the PPMI baseline and longitudinal dataset. Background: The NSD-ISS Working Group…
  • 2024 International Congress

    The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

    J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)

    Objective: The Pro-LBD cohort study is a prospective, long-term, clinic-biological cohort study of participants who are stratified by their risk of developing a Lewy body…
  • 2024 International Congress

    Prediction of amyloid positivity in Dementia with Lewy bodies using the early-phase 18F-FP-CIT PET images

    SJ. Chung, SH. Kim, PH. Lee, YH. Sohn, Y. Jeong, YJ. Kim (Yongin-si, Republic of Korea)

    Objective: This study aims to explore whether early-phase 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images can predict β-amyloid positivity on 18F-florbetaben (18F-FBB) PET scans…
  • 2024 International Congress

    A case of progressive supranuclear palsy followed by dementia with Lewy bodies

    S. Fujita, H. Kawasaki, R. Yokoyama, Y. Ito, T. Yamamoto (Muroyama-cho, Japan)

    Objective: We report a case of dementia with Lewy bodies (DLB) that was diagnosed one year after the diagnosis of PSP. Background: Progressive supranuclear palsy…
  • 2024 International Congress

    18F-Florzolotau PET uncovers the Co-pathological Heterogeneity of Tau Protein in Dementia with Lewy Bodies

    G. Tang, XY. Li, FT. Liu, J. Wang (Shanghai, China)

    Objective: We attempted to reveal the topographical deposition patterns of tau proteins in the living brains of patients with DLB in vivo by virtue of…
  • 2024 International Congress

    Blood-brain Barrier Breakdown in Dementia with Lewy Bodies

    ZC. Chen, J. Gan, Y. Ji (Beijing, China)

    Objective: To explore the characteristics of BBB breakdown in DLB and find the correlation between leakage and cognitive domains. Background: These years, researchers found that…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley